Company post - HKScan Q1 result 2020 | Inderes: Osakeanalyysit, mallisalkku, osakevertailu & aamukatsaus

Hei!

Luo ilmainen tili jotta voit seurata yrityksiä, osallistua foorumin keskusteluun sekä kommentoida meidän sisältöä. Valitse sinulle sopivin tili.

Oliko sinulla jo tili?

HKScan Q1 result 2020 EN

Q1/2020 net sales increased by almost 7% and comparable EBIT improved by EUR 6.2 million but was still EUR -3.9 million negative.

Trade. (HKScan)

Buy Sell

We reiterate our accumulate recommendation for LeadDesk and revise the target price to EUR 11.50 (previously EUR 9.0). In our estimate, LeadDesk’s investment case has progressed to a phase that is attractive from an investor’s perspective.

Successful internationalisation is the decisive factor

Efecte Company report - 23.12.2019

After the IPO, Efecte’s progress has remained weaker than expected as the acceleration of the growth of international operations has taken more time than estimated and the benefits from the considerable growth investments have not been at the expected level.

Story’s next chapter begins

Revenio Group Company report - 22.10.2019

Revenio’s investor story remains interesting, as the strategy’s next phase begins after the acquisition of CenterVue.

Hei!